FTC stated that the 'Big 3' PBM organisations collectively generated over £5.94 billion ($7.3 billion) in revenue from 2017 to 2022.

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

and UnitedHealth Group Inc (NYSE:UNH) were down around 1% after the Federal Trade Commission (FTC) accused their pharmacy benefit manager units of imposing significant price markups on specialty ...

The City of Greensboro, North Carolina, which provides public safety, emergency, and health services to over 300,000 residents and spends millions annually on insulin medications, filed a lawsuit last ...

The lawsuit – which has been anticipated since the FTC published a damning report on the PBM sector in July – names CVS Health's Caremark, UnitedHealth Group's Optum, and Cigna's Express ...

Nissan Motor plans to procure batteries for electric vehicles sold in the U.S. from South Korea's SK On from around 2028 ...

Sen. James Lankford has been trying to pass legislation in response to an industry he believes will leave small towns without ...

Russia's legendary cold winters are not what they used to be. Early snowdrops, mild January temperatures and a lack of ice on ...